Results 61 to 70 of about 356,569 (161)

Human monkeypox preparedness in Latin America – Are we ready for the next viral zoonotic disease outbreak after COVID-19?

Brazilian Journal of Infectious Diseases, 2022
Sergio Cimerman, Alberto Chebabo, Clovis Arns da Cunha, Alexandre Naime Barbosa, Alfonso J. Rodríguez-Morales   +4 more
doaj   +1 more source

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?

Critical Care Explorations, 2020
Objectives:. Aspergillus coinfection in coronavirus disease 2019 patients has rarely been described but may be occurring among coronavirus disease 2019 patients admitted to ICUs.
Karlyn D. Beer, MS, PhD, Brendan R. Jackson, MD, MPH, Tom Chiller, MD, MTMH, Paul E. Verweij, MD, PhD, Frank L. Van de Veerdonk, MD, PhD, Joost Wauters, MD, PhD   +5 more
doaj   +1 more source

Prevención e identificación temprana de casos sospechosos COVID-19 en el primer nivel de atención en Centro América

Atención Primaria, 2021
Karla Iveth Henriquez-Marquez, Lysien I. Zambrano, Kovy Arteaga-Livias, Alfonso J. Rodríguez-Morales   +3 more
doaj   +1 more source

Asthma and prognosis of coronavirus disease 2019

World Allergy Organization Journal, 2022
It is well-known that asthma patients show compromised production of antiviral interferons and lower expression of ACE-2, most likely owing to ACE-2 expression is inversely correlated with type 2 (Th2: T helper 2) cytokine levels of asthmatics. However, COVID-19 patients with poor outcomes show early vigorous type I interferon expression. This does not
openaire   +3 more sources

Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients

Critical Care Explorations, 2020
Objectives:. Coronavirus disease 2019 is caused by severe acute respiratory syndrome-coronavirus-2 infection to which there is no community immunity. Patients admitted to ICUs have high mortality, with only supportive therapies available.
Douglas D. Fraser, MD, PhD, Gediminas Cepinskas, DVM, PhD, Marat Slessarev, MD, MSc, Claudio Martin, MD, MSc, Mark Daley, PhD, Michael R. Miller, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, Eric K. Patterson, PhD, Claudia C. dos Santos, MD, MSc, on behalf of the Lawson COVID-19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn   +24 more
doaj   +1 more source

One year after the arrival of COVID-19 in Latin America: what have we learned in Brazil and other countries?

Brazilian Journal of Infectious Diseases, 2021
Sergio Cimerman, Alberto Chebabo, Clovis Arns da Cunha, Alfonso J. Rodríguez-Morales   +3 more
doaj   +1 more source

Coronavirus Disease 2019 and the Kidney.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2021
Coronaviruses are ubiquitous pathogens and have caused epidemics in the recent past. Coupled with globalization, they have the potential to transform into the pandemic, as is the case of coronavirus disease 2019 (COVID-19). Primarily to start as a respiratory illness, they are known to cause systemic disease and affect many organ systems.
Ajay Jaryal, Sanjay Vikrant
openaire   +2 more sources

Coronavirus disease 2019 and pregnancy [PDF]

American Journal of Obstetrics and Gynecology, 2021
Rasmussen, Sonja A., Jamieson, Denise J.
openaire   +2 more sources

„Coronavirus disease 2019“ und Frailty

Zeitschrift für Gerontologie und Geriatrie, 2022
The course of coronavirus disease 2019 (COVID-19) varies from individual to individual. People of advanced age with comorbidities have been identified as having a higher risk for severe disease or to die from COVID-19. Frailty is an essential risk factor in this respect. Approximately one fifth of the middle European population are older than 65 years,
openaire   +2 more sources

Coronavirus disease 2019 as a syndemic [PDF]

Reviews in Medical Virology, 2021
openaire   +2 more sources